SPWCX Mutual Fund

SPWCX Mutual Fund

NAV$9.56
See how much of SPWCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$1M
Expense Ratio
2.06%
Dividend Yield (Current)
-
Holdings
98
Inception Date
Feb 24, 2012
Fund Family
American Beacon Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+11.54%
1 Year+10.49%
3 Year+19.31%
5 Year+2.46%
10 Year+11.00%

Asset Allocation

Stocks: 98.29%
Cash: 1.71%
See how much of SPWCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
HALOHalozyme Therapeutics Inc2.03%
LGNDLigand Pharmaceuticals, Inc.1.99%
RGENRepligen Corp1.93%
FCFSFirstcash Inc1.91%
XMTRXometry, Inc.1.88%
Top 10 Concentration: 18.55%Report Date: Aug 31, 2026
Download all 98 holdings for SPWCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$3.68
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

SPWCX Mutual Fund Overview

SPWCX Mutual Fund (American Beacon Stephens Small Cap Growth Fund C Class) is managed by American Beacon Funds with $1.2M in net assets. SPWCX expense ratio is 2.06%, holding 98 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2012-02-24.

SPWCX performance shows a YTD return of 11.54%. The 1-year return is 10.49% and the 5-year return is 2.46%.

SPWCX top holdings include Halozyme Therapeutics Inc (2.0%), Ligand Pharmaceuticals, Inc. (2.0%), Repligen Corp (1.9%), Firstcash Inc (1.9%), Xometry, Inc. (1.9%). Go to all SPWCX holdings, SPWCX sectors, or SPWCX dividends.

SPWCX can be compared against other funds. Use SPWCX overlap to find shared positions, or SPWCX vs another fund for a side-by-side view. SPWCX alternatives are available via the screener, along with tax-loss harvesting opportunities.